Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > bought deal

<< Previous

Bullboard Posts

Next >>

Comment by JonEcashon Feb 04, 2021 1:16pm

142 Views

Post# 32471615

RE:RE:RE:RE:RE:RE:bought deal

I'm leaning towards what BioTeck is speculating. If it was just to be a reverse split everything would have been better planned. Why do the bought deal and then double it in less than 12 hours? This smells of things having to move very quickly for a specific, strategic purpose. I'm hearing it's not easy to get in on the bought deal either, which is a good sign. As others have said, $20M is a LOT of cash for a Company like this, and can be used to accelerate so much.

J$

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks